Scientists have long theorized about a network of pathways in the brain that are believed to clear metabolic proteins that would otherwise build up and potentially lead to Alzheimer’s and other forms…
Key Takeaways: A new systematic review led by the Harvard Pilgrim Health Care Institute examined a wide body of evidence documenting pediatric mental health outcomes in the period following FDA Black-Box Warnings…
Key points: Among more than 15,000 SNAP participants across 35 states, food insufficiency increased by 8.4% after pandemic-era Supplemental Nutrition Assistance Program (SNAP) emergency allotments expired. Emergency allotments provided participants up to…
Most U.S. hospital emergency departments — lacking staffing, training and equipment — are not fully prepared to care for children. Maximizing their readiness to handle pediatric emergencies would be a cost-effective way…
The National Institutes of Health recently awarded $2.2 million to Alissa Rothchild, assistant professor in the Department of Veterinary and Animal Sciences at the University of Massachusetts Amherst and an expert in tuberculosis…
Imagine a world where your own immune cells are transformed into cancer-fighting superheroes. This is the promise of CAR-T cell therapy, a groundbreaking treatment that’s already saving lives. In this therapy, patients’…
Parkinson’s disease is most known for its movement-related symptoms: tremors and rigidity, slowness and falls, caused by the loss of the brain’s dopamine-producing neurons. However, about half of Parkinson’s patients also experience…
Researchers at Virginia Tech are using wrist-worn voice recorders to capture real-world data to better understand what happens when people lose their balance. The study, led by Michael Madigan in the College of Engineering, builds…
Researchers have a new battle tactic to fight drug-resistant bacterial infections. Their strategy involves using collections of bacteriophages, viruses that naturally attack bacteria. In a new study, researchers at the University of Chicago…
Brain molecule reverses movement deficits of Parkinson’s, offering new therapeutic target A research team from the University of California, Irvine is the first to reveal that a molecule in the brain –…
